Articles Tagged With:
-
Physical Activity and Diet of U.S. Adults Following Bariatric Surgery
Patients who underwent bariatric surgery reported more physical activity and less energy intake than those who were eligible for, but did not undergo, bariatric surgery; however, physical activity still did not reach recommended levels.
-
Do Anti-Inflammatory Drugs Cause More Chronic Pain?
Acute inflammation may protect against the development of chronic pain through neutrophil activation. Using nonsteroidal anti-inflammatory drugs may blunt that response and contribute to chronic pain.
-
Active Life, Healthy Mind
Daily exercise, frequent social interactions, and even performing regular household chores can lower dementia risk.
-
Ethical Precision Medicine Requires Relying on Scientific Evidence, Safeguarding Information
American College of Physicians offers guidance as genome sequencing technology progresses quickly.
-
Patients Share Preferences About Data Privacy
Most want security and accountability, are concerned about who can access their information and for what purposes.
-
TJC Urges Caution About Cognitive Biases in Diagnostics
So-called “diagnostic overshadowing” can lead clinicians to miss the real causes of health problems.
-
COVID-19 and Headache
Headache is a common feature of acute COVID-19 infection, as well as a long-standing feature of “long COVID” after recovery from the acute infection. Treatment is symptomatic, based on the characteristics of the headache syndrome.
-
Myopathy Is Associated with Post-COVID-19 Fatigue
Prolonged fatigue after COVID-19 infection may be associated with evidence of myopathy, based on physical examination, electromyography, and muscle biopsy.
-
Risk Factors Associated with Alzheimer’s Disease and Related Dementias in the United States
Two independent analyses of U.S. national surveys support evidence that targeted risk-reduction strategies may reduce the burden of Alzheimer’s disease in the population.
-
Noradrenergic Drugs for the Symptomatic Treatment of Alzheimer’s Disease
This meta-analysis provides evidence that drugs modulating the noradrenergic system could be effective in treating cognitive symptoms and apathy in patients with Alzheimer’s disease.